monarch 1: abemaciclib monotherapy for hr mbc
Published 7 years ago • 1.2K plays • Length 5:06Download video MP4
Download video MP3
Similar videos
-
9:18
monarch 3: abemaciclib with endocrine therapy for mbc
-
5:04
abemaciclib fulvestrant at progression of hr mbc
-
6:15
abemaciclib with hormone therapy for hr mbc
-
2:02
dr. dickler on monarch 1 results in hr /her2- breast cancer
-
7:17
abemaciclib for er mbc
-
0:53
postmonarche: abemaciclib fulvestrant in hr /her2- mbc following cdk4/6i & endocrine therapy
-
7:59
what are cdk 4/6 inhibitors for breast cancer?
-
30:58
new treatment plan 2024 - metastatic breast cancer (bone mets) - abemaciclib & anastrozole
-
6:43
#abemaciclib | uses, dosage, side effects & mechanism | verzenio
-
4:19
abemaciclib plus nsai for hr , her2- advanced breast cancer - monarch 3 interim data
-
8:39
final overall survival analysis of monarch 1
-
1:08
4-year monarche results: increasing benefits with abemaciclib et for er /her2- high-risk early bc
-
4:45
abemaciclib monotherapy’s role in hr breast cancer
-
4:45
monarch 3: abemaciclib as initial therapy for patients with hr /her2- advanced breast cancer
-
1:11
debu tripathy, md regarding the monarch 1 (abemaciclib) study
-
4:19
monarche results: abemaciclib plus endocrine therapy in high-risk early breast cancer
-
4:03
monarche 4-year: abemaciclib endocrine therapy for hr , her2-, node-positive, high-risk early bc
-
2:10
monarche: adjuvant abemaciclib endocrine therapy in patients with hr , her2- high-risk ebc
-
1:33
ongoing trial of abemaciclib and pembrolizumab in hr /her2-negative breast cancer
-
1:41
postmonarch: abemaciclib with fulvestrant in pretreated hr /her2- breast cancer
-
2:37
#esmo22 highlights on abemaciclib nsai in hr /her2- advanced breast cancer: the monarch 3 study
-
7:09
abemaciclib for hr-positive metastatic breast cancer